Navigation Links
TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston
Date:3/24/2009

Hundreds of Sessions, led by the Industry's Preeminent Thought Leaders, will Examine Nanotechnology's Role in Cancer Prevention, Diagnosis and Treatment

CAMBRIDGE, Mass., March 24 /PRNewswire/ -- TechConnect World, in association with the Nano Science and Technology Institute (NSTI), and the Clean Technology and Sustainable Industries Organization (CTSI), today announced the CancerNano 2009 Symposium, scheduled to take place at TechConnect World, May 3-7, at the George R. Brown Convention Center in Houston, Texas.

The two-day CancerNano 2009 Symposium brings together the foremost thought-leaders from the academic, industry and government sectors, to discuss clinical translation of nanotechnology for cancer diagnosis, prevention and treatment. The Symposium is co-chaired by Mansoor Amiji, who is the Professor and Interim Chair of Pharmaceutical Sciences Department and Co-Director of the Nanomedicine Education and Research Consortium (NERC) at Northeastern University, as well as Vladimir Torchilin, the Distinguished Professor of Pharmaceutical Sciences, and Director of the Center for Pharmaceutical Biotechnology and Nanomedicine at Northeastern University.

Featured sessions in the CancerNano 2009 Symposium include:

  • Keynote address - Cancer Grand Challenges, by John Mendelsohn
  • Keynote address - Nanotechnology Opportunities in Cancer, by Mauro Ferrari
  • Early Cancer Detection with Nanotechnology, by Rebecca Richards-Kortum
  • Thermal Therapy for Cancer, by Steven A. Curley
  • Cancer Target Identification and Validation, by Renata Pasqualini
  • Enhancing Cancer Therapy with Nano-Delivery Systems, by Jim Klostergaard
  • Targeted Nanoparticles for Cancer Therapy, by Ananth Annapragada
  • Lessons Learned in Cancer Nanotechnology, by Scott E. McNeil
  • Clinical Translation of Cancer Nanotechnology, by Piotr Grodzinski
  • and a Food & Drug Administration Perspective, by the FDA's Wendy Sanhai

"We're extremely fortunate to host this symposium in Houston, where we can draw heavily upon the experts from the MD Anderson Cancer Center, Rice University, and so many others that are playing a central role in CancerNano research," said Dr. Mansoor Amiji. "I'd like to personally thank Dr. Mauro Ferrari and his team for their contributions to this program, and I'm looking forward to working with him, and all of our presenters at the Symposium."

The CancerNano 2009 Symposium is sponsored by the National Cancer Institute, and the National Institutes of Health. More than a hundred additional sessions are scheduled throughout the May 3-7 event. NSTI is still accepting abstracts for "Poster Presentations," which allow researchers to share their research with colleagues, fellow presenters, and the entire audience attending the TechConnect World Conference & Expo. The Deadline to submit an abstract is March 27th. Additional details are available at: http://www.nsti.org/Nanotech2009/symposia/Cancer.html.

The CancerNano 2009 Symposium sessions are among the more than 2,700 presentations featured at the Nanotech '09, Clean Technology '09, and TechConnect Summit events. An extensive lineup of Keynote addresses, from companies such as: Continental Airlines, Lockheed Martin, NREL, Exelon, and many others, will provide the insights of top executives from the largest companies in the world - who are actively involved in some of the most significant projects across the clean, bio and nano tech industries.

To reserve media credentials for these combined events, please contact Todd Keefe at todd@firpr.com. And for additional information on these three events, please visit: www.techconnectworld.com.

About NSTI:

The Nano Science and Technology Institute (NSTI; www.nsti.org) advances and integrates nano and other advanced technologies through education, conventions, business publishing, and research services. NSTI produces the annual Nanotechnology conference and trade show, which attracts more than 5,000 industrial, academic, business and governmental attendees from around the word. It is the largest gathering of the nanotechnology industry in the U.S. NSTI was founded in 1997 as a result of the merger between various scientific societies, and is headquartered in Cambridge, Massachusetts with offices in California and Switzerland.

    Contacts:
    Todd Keefe
    617 262 1968 x 101
    todd@firpr.com


'/>"/>
SOURCE NSTI, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. TechConnect World Publishes Conference Agenda Featuring More than 2,700 Presentations Addressing Nano, Bio and Clean Technologies
2. TechConnect World 2009 Announces January 28th Last Call for Speaker-Proposals
3. TechConnect World 2009 Matches Tomorrows Technology Solutions with Todays Business Needs for Clean-Technology, Biotechnology and Nanotechnology
4. Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
5. Zymes Omega Solutions Bottles and Launches the Worlds First Omega-3 Enhanced Water
6. 3rd Global Jatrophaworld Training 2009... Set to Create and Build a Sustainable non-food Biodiesel Industry
7. Kibow Biotech Strongly Supports World Kidney Day for Maintenance of Healthy Kidney Function
8. Satyam Wins Consumer Health World Award for Tele-Ophthalmology Program
9. Kentucky Ale Will Be the Official Beer of the Alltech FEI World Equestrian Games
10. IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its Embracing Human Technology Interactions Media Event
11. Bio-Matrix Scientific Group, Inc. Highlighted in LifeSciencesWorld.com Special Report; Stem Cell Market Projected to Exceed $8 Billion Worldwide by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... New York , March 22, 2017 ... is largely fragmented, states a research report by Transparency ... S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted ... in 2015. The prominent players in this market are ... expand their product portfolio, which is likely to lead ...
(Date:3/22/2017)... /PRNewswire/ - FACIT announced a seed stage investment ... start-up created by FACIT focused on developing a ... with non-dilutive capital, achieves a targeted $3.0M financing ... Propellon to accelerate the nomination of a candidate ... entering a strategic partnership for clinical trials in ...
Breaking Biology Technology:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
Breaking Biology News(10 mins):